The effectiveness of the combination of thermosensitive liposomes of plumbagin and hyperthermia is described. Small-sized, thermosensitive liposomes were prepared by thin film hydration and subsequent sonication. The liposomes were characterized for size, phase transition temperature, in vitro drug release and stability. The results of particle size analysis indicated that almost 90% of the vesicles were below 0.19 μm size. The phase transition temperature of the liposomes as determined by differential scanning calorimetry was found to be 41.32°C. The results of in vitro release studies in phosphate buffered saline + mouse plasma indicated that maximum drug release (51.25%) occurred at 42°C compared to the less than 9% release at 37°C. Better stability profile was observed when the plumbagin liposomes were stored at 4°C. When combined with localised hyperthermia (43°C, 30 min or 1 h), liposomal plumbagin administered intravenously to C57BL/6J mice bearing melanoma exhibited better anticancer activity as compared to animals treated with an equivalent dose of free plumbagin with or without hyperthermia, which was evident by enhanced volume doubling time and growth delay.
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science